Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2015

Goodwill And Intangible Assets Disclosure [Abstract]

Summary of Changes in Company's Recorded Goodwill

The following is a summary of changes in the Company’s recorded goodwill during the year ended December 31, 2015 (in thousands):

	Amount
Balance at December 31, 2014	$	24,041
Relative fair value allocation of goodwill attributable to IgDraSol upon sale to NantPharma		(3,415	)
Balance as December 31, 2015	$	20,626

Summary of Company's Identifiable Intangible Assets

A summary of the Company’s identifiable intangible assets as of December 31, is as follows (in thousands):

	December 31, 2015
	Gross Carrying Amount		Accumulated Amortization		Intangibles, net
Customer relationships	$	1,320	$	536	$	784
Acquired technology		3,410		358		3,052
Patent rights		90		14		76
Total intangible assets	$	4,820	$	908	$	3,912
	December 31, 2014
	Gross Carrying Amount		Accumulated Amortization		Intangibles, net
Customer relationships	$	1,320	$	272	$	1,048
Acquired technology		3,410		182		3,228
Patent rights		90		9		81
Total intangible assets	$	4,820	$	463	$	4,357

Schedule of Estimated Future Amortization Expense Related to Intangible Assets

Estimated future amortization expense related to intangible assets at December 31, 2015 is as follows (in thousands):

Years Ending December 31,	Amount
2016	$	445
2017		445
2018		436
2019		181
2020		181
Thereafter		2,224
Total	$	3,912